Bard succession plan
This article was originally published in The Gray Sheet
Executive Summary
Group President Timothy Ring's accession to chairman and CEO, effective upon William Longfield's retirement Aug. 7, is confirmed by the company Feb. 13. The move was anticipated last fall although the firm had insisted the choice was not yet final (1"The Gray Sheet" Oct. 21, 2002, In Brief). Ring, 45, joined the firm in 1992 as VP-human resources, became group VP-international in 1993, and assumed his current responsibilities in 1997, most recently supervising the firm's Vascular and Specialty Access businesses. Bard Group President John Weiland, 47, will become president and chief operating officer in August under the succession plan...
You may also be interested in...
Bard prepares to Ring in New Year
Group President Timothy Ring is expected to succeed William Longfield as CEO in 2003. Ring, 45, has a background in personnel management. He joined the company in 1992 as VP-human resources after a 10-year career with Abbott, where he ultimately rose to director of personnel in the Hospital Products division. Ring was promoted to Bard group VP in 1993 and assumed his current responsibilities in 1997. Longfield, who announced plans to retire during this year's aborted merger with Tyco, is expected to stay on as chairman until he turns 65 in August. Bard maintains, however, that the selection process may not be completed until the spring of 2003...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.